title: Bisphosphonate prescriptions in men with androgen deprivation therapy use.
authors.affiliation: Department of Medicine, University Health Network, Toronto, Ontario, Canada.
authors.forename: Husayn
authors.initials: H
authors.lastname: Gulamhusein
authors.affiliation: Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Lingsong
authors.initials: L
authors.lastname: Yun
authors.affiliation: Department of Medicine, University Health Network, Toronto, Ontario, Canada.
authors.forename: Angela M
authors.initials: AM
authors.lastname: Cheung
authors.affiliation: Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Rinku
authors.initials: R
authors.lastname: Sutradhar
authors.affiliation: Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Lawrence
authors.initials: L
authors.lastname: Paszat
authors.affiliation: Radiation Medicine Program, University Health Network, Toronto, Ontario, Canada.
authors.forename: Padraig
authors.initials: P
authors.lastname: Warde
authors.affiliation: Department of Medicine, University Health Network, Toronto, Ontario, Canada.
authors.forename: Shabbir M H
authors.initials: SM
authors.lastname: Alibhai
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D002170:Canada; D015331:Cohort Studies; D004164:Diphosphonates / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000139:chemically induced / Q000517:prevention & control; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011471:Prostatic Neoplasms / Q000188:drug therapy; D012042:Registries; D012189:Retrospective Studies; D012306:Risk
chemical_list: D000726:Androgen Antagonists; D004164:Diphosphonates